UNSPSC 51281813: Aclarubicin hydrochloride

This classification denotes an aclacinomycin antibiotic with the molecular formula C42H53NO15.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 501948RI66, chemically known as 1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-o-(2,6-dideoxy-4-o-((2r-trans)-tetrahydro-6-methyl-5-oxo-2h-pyran-2-yl)-alpha-l-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-l-lyxo-hexopyranosyl)oxy)-, methyl ester, hydrochloride, (1r-(1alpha,2beta,4beta))- but more generally known as aclarubicin hydrochloride, which bears US NIH Compound Identifier 153751.

UNSPSC 51281813 Aclarubicin hydrochloride is a Commodity code for a specific oncology pharmaceutical, yet the recent state and local opportunities tagged under it show little activity directly aligned with this product. Instead, the indexed solicitations involve broader pharmaceutical procurement — antibiotics, opioid-reversal agents, and related medical supplies — suggesting either category-tagging inconsistency or procurement patterns that diverge from the nominal code scope. State and local health departments and county public-health authorities are the primary issuing bodies pursuing pharmaceutical acquisitions under this code tier, typically through piggyback agreements with established pharmaceutical consortiums or direct competitive bids. The work encompasses warehouse supply contracts for high-volume pharmaceutical distribution, quarterly delivery cycles, and multi-year terms with renewal options.

Activity spans Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 for $2,999,999.11 over three years, covering Doxycycline Hyclate and Ciprofloxacin Hydrochloride via the MMCAP Infuse consortium; Seminole County, Florida issued an IFB on June 30, 2026 seeking 1,900 units of Naloxone and 800 drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford. Neither opportunity directly involved aclarubicin hydrochloride procurement. Bidders on such contracts must meet drug-free workplace and E-Verify compliance, carry workers' compensation and commercial general liability insurance, and accept fixed-fee pricing structures; no explicit SBE, MBE, or set-aside designations appeared in the indexed records.